Triazolam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Triazolam.
Product ID | 21695-284_1da7457b-7225-4950-8108-bbbd8f78f883 |
NDC | 21695-284 |
Product Type | Human Prescription Drug |
Proprietary Name | Triazolam |
Generic Name | Triazolam |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1994-06-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA074224 |
Labeler Name | Rebel Distributors Corp |
Substance Name | TRIAZOLAM |
Active Ingredient Strength | 0 mg/1 |
Pharm Classes | Benzodiazepine [EPC],Benzodiazepines [CS] |
DEA Schedule | CIV |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1994-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA074224 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1994-06-01 |
Inactivation Date | 2019-09-24 |
Marketing Category | ANDA |
Application Number | ANDA074224 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-11-18 |
Inactivation Date | 2019-09-24 |
Ingredient | Strength |
---|---|
TRIAZOLAM | .25 mg/1 |
SPL SET ID: | 73db8a0e-02a9-4613-8feb-e847c965d34f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0054-4858 | Triazolam | Triazolam |
0054-4859 | Triazolam | Triazolam |
21695-284 | Triazolam | Triazolam |
21695-303 | Triazolam | Triazolam |
43063-996 | Triazolam | Triazolam |
43353-451 | Triazolam | triazolam |
50090-0522 | Triazolam | triazolam |
50090-4733 | Triazolam | Triazolam |
50436-3718 | Triazolam | triazolam |
50742-645 | Triazolam | Triazolam |
50742-646 | Triazolam | Triazolam |
55289-787 | Triazolam | triazolam |
59762-3717 | Triazolam | triazolam |
59762-3718 | Triazolam | triazolam |
67544-725 | Triazolam | Triazolam |
63629-2956 | Triazolam | Triazolam |
0009-0017 | Halcion | triazolam |